Severe hemolytic anemia associated with Hb Volga [beta27(B9)Ala-->Asp]: GCC-->GAC at codon 27 in a Turkish family

Am J Hematol. 2004 Aug;76(4):378-82. doi: 10.1002/ajh.20128.

Abstract

A boy presented at age 4 years with severe congenital hemolytic anemia characterized by highly elevated reticulocyte count (30-50%) and prominent basophilic stippling. Hb had been 4 g/dL at age 7 months. The patient was on a monthly transfusion regimen up to the age of 7 years, when he underwent splenectomy. After removal of the spleen, his Hb stabilized at 11 g/dL. No abnormal pattern was detected in hemoglobin electrophoresis at pH 9 and 6. In-vitro globin synthesis revealed the presence of an abnormal beta-chain in front of the gamma-chain. The beta(A)/beta(X) ratio was 0.77 at 30 min and 0.74 at 2 hr of incubation. Molecular analysis revealed that the patient had GCC-->GAC alteration at codon 27 (beta27(B9)Ala-->Asp) causing the abnormal hemoglobin Volga. The beta-cDNA derived from the beta-Hb Volga allele could be differentiated from HbA beta-cDNA on silver-stained gel. No imbalance in the mRNA of beta(A)/beta(Hb Volga) ratio was observed.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anemia, Hemolytic, Congenital / blood
  • Anemia, Hemolytic, Congenital / drug therapy
  • Anemia, Hemolytic, Congenital / genetics*
  • Anemia, Hemolytic, Congenital / surgery
  • Blood Protein Electrophoresis
  • Child, Preschool
  • Codon / genetics
  • Combined Modality Therapy
  • Deferoxamine / therapeutic use
  • Deoxyribonucleases, Type II Site-Specific
  • Female
  • Globins / genetics
  • Hemoglobins, Abnormal / genetics*
  • Hemoglobins, Abnormal / isolation & purification
  • Humans
  • Iron Chelating Agents / therapeutic use
  • Male
  • Polymorphism, Restriction Fragment Length
  • Pregnancy
  • Pregnancy Complications, Hematologic / etiology
  • Reticulocyte Count
  • Silver Staining
  • Splenectomy
  • Thrombosis / etiology
  • Turkey

Substances

  • Codon
  • Hemoglobins, Abnormal
  • Iron Chelating Agents
  • hemoglobin Volga
  • Globins
  • Deoxyribonucleases, Type II Site-Specific
  • GGCC-specific type II deoxyribonucleases
  • Deferoxamine